Regulation 4 Exemptions from requirement to carry out risk assessments

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

reg. 4(2)(c) words substituted by Genetically Modified Organisms 2019 reg. 2(2)(a)
reg. 4(2)(e) substituted by Genetically Modified Organisms 2019 reg. 2(2)(b)
reg. 4(2)(f) inserted by Genetically Modified Organisms 2019 reg. 2(2)(c)
reg. 4(2)(b)(i) words substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 4(2)(a)
reg. 4(2)(a)(ii) words substituted by Genetically Modified Organisms (Deliberate Release) 2019 reg. 11
reg. 4(2)(b)(i) words substituted by Genetically Modified Organisms (Contained Use) 2001 reg. 31(3)(b)
reg. 4(2)(b)(ii) words substituted by Genetically Modified Organisms (Contained Use) 2001 reg. 31(3)(c)
reg. 4(2)(e) and semicolon added by Genetically Modified Organisms (Deliberate Release and Risk Assessment) 1997 reg. 3
reg. 4(2)(b)(ii) words substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 4(2)(b)
reg. 4(2)(c) words substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 4(2)(c)
reg. 4(2)(e) words substituted by Pesticides, Genetically Modified Organisms and Fertilisers 2018 reg. 4(2)(d)

(1)

A person who imports or acquires genetically modified organisms shall be exempt from the requirements of Article 5(1)(a) of the Order in so far as they relate to the protection of human health.

(2)

A person who imports or acquires genetically modified organisms shall be exempt from the requirements of Article 5(1)(a) of the Order where the organisms to be imported or acquired—

(a)

are genetically modified micro-organisms;

(b)

are organisms, other than micro-organisms, which are modified by means of:—

(i)

the application of the techniques which, by virtue of Part II of Schedule 1 to the Contained Use Regulations, are not considered to result in genetic modification; or

(ii)

the application of the techniques to which, by virtue of regulation 3(3) of and Part III of Schedule 1 to the Contained Use Regulations, those Regulations do not apply;

(c)

are or are contained in a medicinal product for human or veterinary use which is the subject of a market authorisation under Council Regulation (EEC) No. 2309/93^f1;

(d)

consist of, or are included in, an approved product as defined in the Genetically Modified Organisms (Deliberate Release) Regulations (Northern Ireland) 1994^f2 which is imported or acquired in accordance with the conditions and limitations to which the use of the product is subject.

Annotations

Footnotes

f1: O.J. No. L214, 24.8.93, p. 1
f2: S.R. 1994 No. 144; Relevant amending regulations are S.R. 1995 No. 413